Clinical Trial Update: PPAR-gamma: a Novel Therapeutic Target for Asthma? [Phase 4]

View source ↗

Summary

A Phase 4 trial exploring PPAR-gamma as a therapeutic target for asthma has been terminated. The update provides no trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: University of Nottingham | Conditions: Asthma | Phase 4 | Status: TERMINATED